The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABBVIE INC COM 00287Y109 10,800 110,000 SH   SOLE   110,000 0 0
ALEXION PHARMACEUTICALS INC COM 015351109 9,540 85,000 SH   SOLE   85,000 0 0
AMGEN INC COM 031162100 7,783 33,000 SH   SOLE   33,000 0 0
ARCUS BIOSCIENCES INC COM 03969F109 3,078 124,404 SH   SOLE   124,404 0 0
ARENA PHARMACEUTICALS INC COM NEW 040047607 5,015 79,672 SH   SOLE   79,672 0 0
BIOMARIN PHARMACEUTICAL INC COM 09061G101 6,153 49,889 SH   SOLE   49,889 0 0
BRISTOL-MYERS SQUIBB CO COM 110122108 10,084 171,493 SH   SOLE   171,493 0 0
CYMABAY THERAPEUTICS INC COM 23257D103 1,002 287,000 SH   SOLE   287,000 0 0
EIGER BIOPHARMACEUTICALS INC COM 28249U105 1,920 200,000 SH   SOLE   200,000 0 0
FATE THERAPEUTICS INC COM 31189P102 5,335 155,505 SH   SOLE   155,505 0 0
GW PHARMACEUTICALS PLC ADS 36197T103 2,700 22,000 SH   SOLE   22,000 0 0
HORIZON THERAPEUTICS PUB LTD SHS G46188101 4,704 84,626 SH   SOLE   84,626 0 0
IQVIA HLDGS INC COM 46266C105 5,675 40,000 SH   SOLE   40,000 0 0
MOMENTA PHARMACEUTICALS INC COM 60877T100 2,928 88,000 SH   SOLE   88,000 0 0
MYOKARDIA INC COM 62857M105 5,507 57,000 SH   SOLE   57,000 0 0
ORASURE TECHNOLOGIES INC COM 68554V108 917 78,875 SH   SOLE   78,875 0 0
TRANSLATE BIO INC COM 89374L104 1,613 90,000 SH   SOLE   90,000 0 0
VERTEX PHARMACEUTICALS INC COM 92532F100 6,475 22,305 SH   SOLE   22,305 0 0